In:
Malaysian Journal of Pharmaceutical Sciences, Penerbit Universiti Sains Malaysia, Vol. 20, No. 2 ( 2022-11-16), p. 105-120
Abstract:
Battling the COVID-19 pandemic still is the main agenda of many countries in the world today. This study aims to describe the clinical characteristics of COVID-19-related deaths in Malaysia in 2020. Data was obtained from the daily press conference on the COVID-19 situation in Malaysia. Only information on daily deaths were collected for the purpose of this study. A total of 471 COVID-19 deaths reported in Malaysia in 2020. Number of deaths reported for the age categories 〈 65 years old and ≥ 65 years old were almost equal. Majority of deaths were reported among male (66.2%), Malaysian (82.8%), from the state of Sabah (56.3%) and with comorbidities (75.4%). Commonly reported comorbidities were hypertension (53.1%), diabetes mellitus (37.6%) and heart disease (17.4%). Gout was more prevalent and attributed to significant rate of mortality in individuals ≥ 65 years old (6.1%; p = 0.011), whereas obesity (5.8%; p = 0.003) and asthma (4.5%; p = 0.040) were more prevalent and attributed to significant rate of mortality in individuals 〈 65 years old. Heart disease was more prevalent among males (n = 64, 20.5%; p = 0.013) and obesity was more prevalent among women (n = 11, 6.9%; p = 0.003). Furthermore, presence of comorbidities was significantly higher in Malaysians (p 〈 0.001) with two and more comorbidities (p = 0.007). Early detection of risk factors for critical conditions is urgently required to provide adequate supportive treatment.
Type of Medium:
Online Resource
ISSN:
1675-7319
,
2180-429X
DOI:
10.21315/mjps2022.20.2
DOI:
10.21315/mjps2022.20.2.9
Language:
Unknown
Publisher:
Penerbit Universiti Sains Malaysia
Publication Date:
2022
detail.hit.zdb_id:
2744696-7
detail.hit.zdb_id:
3068888-7
Permalink